January 21, 2016 | After receiving FDA approval for its diabetes monitoring device, LabStyle Innovations is looking to raise $11.5 million through public share offering and warrants. LabStyle has earmarked the funds for expanding its production capacity, furthering development of its software, and marketing in the US and other markets. Founded in 2010 and run by CEO Oren Fuerst, LabStyle has developed a small glucose monitor device called ‘Dario’ that gives accurate readings when plugged into a smartphone. The company went public in 2013 when it listed for over-the-counter trading, and later raised $10 million at a valuation of $51 million.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments